Cibus (CBUS) Interest Coverage Ratio Growth (3y) (2019 - 2026)
Cibus (CBUS) Interest Coverage Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 33.30% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 78.77% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 81.16% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -35.50% |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.09% |
| Dec 31, 2025 | 27.47% |
| Sep 30, 2025 | 84.49% |
| Jun 30, 2025 | 80.01% |
| Mar 31, 2025 | 23.53% |
| Dec 31, 2024 | -25.14% |
| Sep 30, 2024 | 13.72% |
| Jun 30, 2024 | 71.09% |
| Mar 31, 2024 | 58.77% |
| Dec 31, 2023 | -31.87% |
| Sep 30, 2023 | -139.05% |
| Jun 30, 2023 | 29.27% |
| Mar 31, 2023 | -29.35% |
| Dec 31, 2022 | -11.77% |
| Sep 30, 2022 | -45.80% |
| Jun 30, 2022 | -57.11% |
| Mar 31, 2022 | 41.28% |
| Dec 31, 2021 | 8.04% |
| Sep 30, 2021 | -255.62% |
| Jun 30, 2021 | -309.50% |